Form 4: McSweeney Erin reports disposition transactions in UNH

Rhea-AI Filing Summary

McSweeney Erin reported disposition transactions in a Form 4 filing for UNH. The filing lists transactions totaling 153 shares at a weighted average price of $293.19 per share. Following the reported transactions, holdings were 11,040 shares.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider McSweeney Erin

Role EVP & Chief People Officer

Type	Security	Shares	Price	Value
Tax Withholding	Common Stock	153.093	$293.19	$45K

Holdings After Transaction: Common Stock — 11,039.545 shares (Direct)

Footnotes (1)

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

McSweeney Erin

(Last) (First) (Middle)

C/O UNITEDHEALTH GROUP INCORPORATED

1 HEALTH DRIVE

(Street)

EDEN PRAIRIE MN 55344

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
UNITEDHEALTH GROUP INC [ UNH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP & Chief People Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/13/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/13/2026		F		153.093	D	$293.19	11,039.545	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

	Faraz A. Choudhry, Attorney-in-Fact for Erin L. McSweeney	02/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did UNH executive Erin McSweeney report?

Erin L. McSweeney reported a tax-withholding disposition of 153.093 UnitedHealth Group common shares. The transaction used code F, meaning shares were withheld or delivered to cover tax obligations rather than sold in an open-market trade, and reflects routine equity compensation administration.

At what price were the UNH shares used for Erin McSweeney’s tax withholding?

The shares involved in Erin McSweeney’s tax-withholding disposition were valued at $293.19 per UnitedHealth Group share. This price is used solely to calculate the value of stock delivered for tax obligations related to equity compensation, not to indicate an open-market sale transaction.

How many UNH shares does Erin McSweeney own after this Form 4 transaction?

After the reported transaction, Erin McSweeney directly owned 11,039.545 UnitedHealth Group common shares. This figure reflects her beneficial ownership following the 153.093-share tax-withholding disposition and indicates her remaining direct equity stake as an executive of the company after the administrative adjustment.

What does transaction code F mean in Erin McSweeney’s UNH Form 4?

Transaction code F on Erin McSweeney’s Form 4 indicates a tax-withholding disposition. It means shares were delivered or withheld to pay an exercise price or tax liability arising from equity awards, rather than representing a discretionary open-market buy or sell decision in UnitedHealth Group stock.

What is Erin McSweeney’s role at UnitedHealth Group mentioned in the Form 4?

The Form 4 lists Erin McSweeney as an officer of UnitedHealth Group with the title EVP & Chief People Officer. This indicates she is a senior executive responsible for people-related functions while also being subject to insider reporting requirements for transactions in UnitedHealth Group common stock.